Redx Pharma PLC (LSE:REDX) - Share price


Stock Report

Redx Pharma PLC REDX

Last Price
GBX15.00

Day Change
2.50|20.00%

As of 22/05/2020
12:34:09 BST | GBX
Minimum 15 Minutes Delay.

Last Close12.50p
Day Range14.50 - 14.50
Mkt Cap28.50Mil
52-Wk Range4.50 - 15.95
Yield %-
ISINGB00BSNB6S51
Volume20,000
P/E-
P/S0.06
P/CF-0.04

Share Price

Total Returns 22/05/2020

 Chg (%)  
More ...
Redx Pharma PLC-4.76 
FTSE 100 TR GBP4.33
 
Financials
201720182019
More ...
Income Statement
Turnover30.470.133.13
Operating Profit13.38-9.20-7.18
Net Profit1.53-8.85-4.32
Reported EPS1.40-7.00-3.40
Balance Sheet
Current Assets27.049.715.81
Non Current Assets0.650.610.55
Total Assets27.6910.326.36
Current Liabilities13.363.954.87
Total Liabilities---
Total Equity14.335.761.49
Cash Flow
Operating Cash Flow14.10-17.90-7.37
Net Change in Cash18.05-17.34-2.77

Company Profile

Redx Pharma PLC is principally engaged in drug discovery, pre-clinical development and licensing. It has an established portfolio of proprietary drug programs that it is developing alone and in partnership with pharmaceutical companies.

Sector

Biotechnology

Index

Next Event 10/06/2020

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-421.60
Op Mrgn-2.29
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanMr. Iain Gladstone Ross
Non-Executive DirectorMr. Peter Eric Presland
Non-Executive DirectorDr. Bernhard Jurgen Kirschbaum
Executive Director, Chief Executive OfficerMs. Lisa Mary Whewell Anson
Executive Director, Chief Financial OfficerDr. James Robert Mead
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.